Advertisement
Risk-stratified breast screening improves the cost-effectiveness of screening

Risk-Stratified Breast Cancer Screening Ups Cost-Effectiveness

0
Risk-stratified screening can reduce overdiagnosis and maintain benefits of screening
In 2010 to 2015

22.9 Percent of U.S. Adults Meet Aerobic, Strength Activity Goals

0
Findings for 18- to 64-year-olds; variation seen in percent meeting guidelines by state, sex, work status
Patients do not appear to mind if doctors have tattoos or piercings

Patients Comfortable With Doctors Having Tattoos, Piercings

0
Survey finds body art does not impact patients' perceptions of competence, professionalism
The World Health Organization Independent High-Level Commission has proposed six recommendations to address the growing epidemic of non-communicable diseases

WHO Calls for Renewed Effort to Combat Chronic Disease

0
Commission makes six recommendations to meet 2030 goals for non-communicable diseases
Cumulative reductions in federal payments to hospitals from 2010 to 2028 are estimated to reach $218.2 billion

Hospitals Face $218B in Federal Payment Cuts From 2010 to 2028

0
11 pieces of legislation plus regulatory changes result in payment reductions beyond those under ACA
Understanding patients' complaints about practice can be instructive for physicians

Patient Complaints Mainly About Rudeness, Rushing, Reproach

0
Complaints of rudeness vary from being verbally attacked by receptionist to feeling insulted by docs
The automated Bone Scan Index is an independent prognostic imaging biomarker of overall survival in metastatic castration-resistant prostate cancer

Automated Bone Scan Index Prognostic for Prostate Cancer

0
aBSI validated as prognostic biomarker of survival in metastatic castration-resistant prostate cancer
The use of primary human papillomavirus testing versus cytology results in reduced likelihood of cervical intraepithelial neoplasia grade 3 or worse at 48 months

HPV Cervical CA Screening Cuts Odds of Later CIN3+ Diagnosis

0
Use of primary HPV testing results in significantly lower odds of CIN3+ compared with cytology testing
For patients with previously treated advanced gastric cancer or gastro-esophageal junction cancer

Pembrolizumab Not Better Than PTX for Advanced Gastric Cancer

0
Survival no better with second-line pembrolizumab than paclitaxel for gastric, gastro-esophageal cancer

June 2018 Briefing – Hematology & Oncology

0
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for June 2018. This roundup includes...